Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ramo Tello

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
European Journal of Neurology|October 24, 2018
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trialJ V Hervás-García, L Ramió-Torrentà, L Brieva-Ruiz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 23, 2014
Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapsesL Grau-López, A Teniente-Serra, M Tintoré, et al.
Cellular & Molecular Immunology|May 7, 2021
Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapyM J Mansilla, S Presas-Rodríguez, A Teniente-Serra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2013
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MSC Ramo-Tello, L Grau-López, M Tintoré, et al.
Neurologia|September 5, 2022
Gadolinium-enhanced brain lesions in multiple sclerosis relapseL Martín-Aguilar, S Presas-Rodriguez, À Rovira, et al.
Revista De Neurologia|May 18, 2010
[Multiple sclerosis epidemiological situation update: pertinence and set-up of a population based registry of new cases in Catalonia]S Otero, J Batlle, I Bonaventura, et al.
Revista De Neurologia|July 13, 2011
[HLA-DRB1 typing in Caucasians patients with neuromyelitis optica]Y Blanco, G Ercilla-González, S Llufriu, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
Neuroimage. Clinical|April 4, 2025
Efficacy of cognitive rehabilitation in cognition and brain networks: A randomised clinical trial in patients with multiple sclerosisE Lopez-Soley, E Martinez-Heras, F Vivo, et al.
Neurologia (Barcelona, Spain)|December 18, 2001
[Present and future of neurology in Spain]I Illa Sendra, J García De Yébenes Prous, C Ramo Tello, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Neurology|October 24, 2018
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trialJ V Hervás-García, L Ramió-Torrentà, L Brieva-Ruiz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 23, 2014
Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapsesL Grau-López, A Teniente-Serra, M Tintoré, et al.
Cellular & Molecular Immunology|May 7, 2021
Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapyM J Mansilla, S Presas-Rodríguez, A Teniente-Serra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2013
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MSC Ramo-Tello, L Grau-López, M Tintoré, et al.
Neurologia|September 5, 2022
Gadolinium-enhanced brain lesions in multiple sclerosis relapseL Martín-Aguilar, S Presas-Rodriguez, À Rovira, et al.
Revista De Neurologia|May 18, 2010
[Multiple sclerosis epidemiological situation update: pertinence and set-up of a population based registry of new cases in Catalonia]S Otero, J Batlle, I Bonaventura, et al.
Revista De Neurologia|July 13, 2011
[HLA-DRB1 typing in Caucasians patients with neuromyelitis optica]Y Blanco, G Ercilla-González, S Llufriu, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
Neuroimage. Clinical|April 4, 2025
Efficacy of cognitive rehabilitation in cognition and brain networks: A randomised clinical trial in patients with multiple sclerosisE Lopez-Soley, E Martinez-Heras, F Vivo, et al.
Neurologia (Barcelona, Spain)|December 18, 2001
[Present and future of neurology in Spain]I Illa Sendra, J García De Yébenes Prous, C Ramo Tello, et al.
Pageof 3